CRT-200.62 The Impact of Ticagrelor on Platelet Reactivity in African Americans: Interim Results of the ACS Ethnicity Study

Little is known regarding the ability of ticagrelorto inhibit platelet reactivity in African Americans (AA) with acute coronary syndrome(ACS). Thus, we performed pharmacodynamicstudies of platelet reactivity following treatment with ticagrelorin AA with ACS. We prospectively enrolled AA with